Asset Details
Do you wish to reserve the book?
Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
Do you wish to request the book?
Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
2013
Overview
Background. Based on a hollow-fiber system model of tuberculosis, we hypothesize that microbiologic failure and acquired drug resistance are primarily driven by low drug concentrations that result from pharmacokinetic variability. Methods. Clinical and pharmacokinetic data were prospectively collected from 142 tuberculosis patients in Western Cape, South Africa. Compartmental pharmacokinetic parameters of isoniazid, rifampin, and pyrazinamide were identified for each patient. Patients were then followed for up to 2 years. Classification and regression tree analysis was used to identify and rank clinical predictors of poor long-term outcome such as microbiologic failure or death, or relapse. Results. Drug concentrations and pharmacokinetics varied widely between patients. Poor long-term outcomes were encountered in 35 (25%) patients. The 3 top predictors of poor long-term outcome, by rank of importance, were a pyrazinamide 24-hour area under the concentration-time curve (AUC) ≦363 mg-h/L, rifampin AUC ≦13 mg-h/L, and isoniazid AUC ≦52 mg-h/L. Poor outcomes were encountered in 32/78 patients with the AUC of at least 1 drug below the identified threshold vs 3/64 without (odds ratio = 14.14; 95% confidence interval, 4.08-49.08). Low rifampin and isoniazid peak and AUC concentrations preceded all cases of acquired drug resistance. Conclusions. Low drug AUCs are predictive of clinical outcomes in tuberculosis patients.
Publisher
Oxford University Press
Subject
/ Adult
/ Aged
/ Antitubercular Agents - blood
/ Antitubercular Agents - pharmacokinetics
/ BACTERIA
/ Bacterial diseases of the respiratory system
/ Biological and medical sciences
/ Carts
/ Female
/ Fundamental and applied biological sciences. Psychology
/ Gumbos
/ Humans
/ Isoniazid - pharmacokinetics
/ Male
/ Multidrug resistant tuberculosis
/ Mycobacterium tuberculosis - drug effects
/ Pyrazinamide - pharmacokinetics
/ Sputum
/ Tuberculosis, Pulmonary - blood
/ Tuberculosis, Pulmonary - drug therapy
